Roche announced the expansion of its collaboration with the U.S. Centers for Disease Control and Prevention, or CDC, to strengthen laboratory capabilities in countries greatly affected by the HIV and tuberculosis, or TB, epidemics. Through the implementation of a public-private partnership, named "Lab Networks for Health," Roche and the CDC will seek to improve HIV and tuberculosis prevention, detection, and treatment outcomes in select countries of Africa, Eastern Europe, Central Asia, and the Western Hemisphere.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on RHHBY:
- Societe Generale upgrades Roche to Buy, says ‘enough is enough’
- Roche upgraded to Buy from Hold at Societe Generale
- Blueprint Medicines to regain global rights to gavreto from Roche
- Roche launch two new antibodies to identify mutations in brain cancer patients
- Roche launches two new antibodies to identify key clinical mutations in patients with brain cancer